185 related articles for article (PubMed ID: 8621911)
21. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle LH; Goodall JC; Gaston JS
Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
[TBL] [Abstract][Full Text] [Related]
22. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
de la Salle H; Houssaint E; Peyrat MA; Arnold D; Salamero J; Pinczon D; Stevanovic S; Bausinger H; Fricker D; Gomard E; Biddison W; Lehner P; UytdeHaag F; Sasportes M; Donato L; Rammensee HG; Cazenave JP; Hanau D; Tongio MM; Bonneville M
J Immunol; 1997 May; 158(10):4555-63. PubMed ID: 9144467
[TBL] [Abstract][Full Text] [Related]
23. Antigen processing and presentation by human trophoblast-derived cell lines.
Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
[TBL] [Abstract][Full Text] [Related]
24. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
25. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
Knittler MR; Alberts P; Deverson EV; Howard JC
Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
[TBL] [Abstract][Full Text] [Related]
26. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
[TBL] [Abstract][Full Text] [Related]
27. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
Seliger B; Ritz U; Abele R; Bock M; Tampé R; Sutter G; Drexler I; Huber C; Ferrone S
Cancer Res; 2001 Dec; 61(24):8647-50. PubMed ID: 11751378
[TBL] [Abstract][Full Text] [Related]
28. The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP Dependent.
Ma W; Stroobant V; Heirman C; Sun Z; Thielemans K; Mulder A; van der Bruggen P; Van den Eynde BJ
J Immunol; 2019 Jan; 202(2):451-459. PubMed ID: 30559321
[TBL] [Abstract][Full Text] [Related]
29. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
31. Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptide.
Brander C; Wyss-Coray T; Mauri D; Bettens F; Pichler WJ
Eur J Immunol; 1993 Dec; 23(12):3217-23. PubMed ID: 8258336
[TBL] [Abstract][Full Text] [Related]
32. A neural network model approach to the study of human TAP transporter.
Brusic V; van Endert P; Zeleznikow J; Daniel S; Hammer J; Petrovsky N
In Silico Biol; 1999; 1(2):109-21. PubMed ID: 11471244
[TBL] [Abstract][Full Text] [Related]
33. Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines.
Young NT; Mulder A; Cerundolo V; Claas FH; Welsh KI
Tissue Antigens; 1998 Oct; 52(4):368-73. PubMed ID: 9820600
[TBL] [Abstract][Full Text] [Related]
34. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.
Neisig A; Wubbolts R; Zang X; Melief C; Neefjes J
J Immunol; 1996 May; 156(9):3196-206. PubMed ID: 8617941
[TBL] [Abstract][Full Text] [Related]
35. A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing.
Yang T; Lapinski PE; Zhao H; Zhou Q; Zhang H; Raghavan M; Liu Y; Zheng P
Clin Cancer Res; 2005 May; 11(10):3614-23. PubMed ID: 15897556
[TBL] [Abstract][Full Text] [Related]
36. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ
J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796
[TBL] [Abstract][Full Text] [Related]
37. MHC class I molecules compete in the endoplasmic reticulum for access to transporter associated with antigen processing.
Knittler MR; Gülow K; Seelig A; Howard JC
J Immunol; 1998 Dec; 161(11):5967-77. PubMed ID: 9834078
[TBL] [Abstract][Full Text] [Related]
38. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
39. Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.
Pentcheva T; Edidin M
J Immunol; 2001 Jun; 166(11):6625-32. PubMed ID: 11359816
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the mutant HLA-A*0201 heavy chain H74L: impaired TAP-dependent peptide loading.
Caley RR; Peace-Brewer AL; Matsui M; Frelinger JA
Hum Immunol; 1999 Sep; 60(9):743-54. PubMed ID: 10527381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
